[The YY3-36 peptide, a new therapeutic weapon against obesity?]

Med Sci (Paris). 2003 May;19(5):537-9. doi: 10.1051/medsci/2003195537.
[Article in French]
No abstract available

Publication types

  • News

MeSH terms

  • Adult
  • Agouti-Related Protein
  • Animals
  • Appetite Depressants / therapeutic use*
  • Cholecystokinin / physiology
  • Colon / metabolism
  • Controlled Clinical Trials as Topic
  • Ghrelin
  • Homeostasis
  • Humans
  • Hypothalamus / physiopathology
  • Intercellular Signaling Peptides and Proteins
  • Intestine, Small / metabolism
  • Leptin / physiology
  • Models, Biological
  • Neuropeptide Y / physiology
  • Obesity / drug therapy*
  • Obesity / physiopathology
  • Peptide Fragments
  • Peptide Hormones / physiology
  • Peptide YY / metabolism
  • Peptide YY / therapeutic use*
  • Pro-Opiomelanocortin / physiology
  • Proteins / physiology
  • Rats
  • Satiety Response / physiology*
  • alpha-MSH / physiology

Substances

  • Agouti-Related Protein
  • Appetite Depressants
  • Ghrelin
  • Intercellular Signaling Peptides and Proteins
  • Leptin
  • Neuropeptide Y
  • Peptide Fragments
  • Peptide Hormones
  • Proteins
  • Peptide YY
  • peptide YY (3-36)
  • alpha-MSH
  • Pro-Opiomelanocortin
  • Cholecystokinin